Literature DB >> 17761703

Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Ann Oncol 2007; 18 Suppl 3: pp 1 75).

M P Coleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17761703     DOI： 10.1093/annonc/mdm363

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Expensive cancer drugs: a comparison between the United States and the United Kingdom.

Authors:  Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

2.  Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales.

Authors:  C Chamberlain; S M Collin; P Stephens; J Donovan; A Bahl; W Hollingworth
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

Review 3.  Can the Spanish care system assume the new costs of medications against cancer?

Authors:  Carlos Camps; Cristina Caballero; Rafael Sirera; Ana Blasco; Diego Cayuela; Mireia Gil; Xavier Badía
Journal:  Clin Transl Oncol       Date:  2008-02       Impact factor: 3.405
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.